XXXiaoxiang Xu

Xiaoxiang Xu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiaoxiang Xu has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Haoquan Zheng

    Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education, School of Chemistry and Chemical Engineering Shaanxi Normal University Xi'an China

    2 shared publications
  • Shuang Li

    Department of Otorhinolaryngology-Head and Neck Surgery Zhongnan Hospital Wuhan University 430071 Wuhan Hubei China

    2 shared publications
  • Weilong Wang

    Department of Otorhinolaryngology-Head and Neck Surgery Zhongnan Hospital Wuhan University 430071 Wuhan Hubei China

    2 shared publications
  • Ya Zhang

    Department of Gastrointestinal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China

    2 shared publications
  • Ben Liu

    Sichuan University

    1 shared publication
  • Guangyin Fan

    College of Chemistry and Materials Science, Sichuan Normal University, Chengdu, China

    1 shared publication

Latest Publications

  • Open Access

    Sea urchin-like La-doped MnO2 for electrocatalytic oxidation degradation of sulfonamide in water

    by Xia Wu, Ming Chen, Shuang Li, Xiaohan Liu, Xiaoxiang Xu, Weilong Wang, Wei Zhang, Rui Cao

    A sea urchin-like La-doped α-MnO2 catalyst was successfully synthesized by a one-step hydrothermal method. The as-prepared material exhibits electrocatalytic activity for water oxidation, achieving an overpotential of 450 mV to reach a catalytic current density of 10 mA/cm2 in 1.0 M KOH solution. The urchin morphology and open tunneling structure can fully expose the rich active sites and facilitate mass transfer during electrochemical oxidation process. Moreover, the catalyst is also applied for sulfonamide degradation due to the generation of strong oxidizing •OH species during the process of water oxidation. The indirect oxidation of sulfonamide by •OH species was confirmed through radical quenching and capture studies. The catalyst degraded sulfonamide antibiotics with up to 40% efficiency within 2 h. The introduction of the heteroatom La3+ into MnO2 led to a redistribution of electrons around Mn, which altered the electron density of the metal sites, lowered the average valence state of Mn, facilitated the production of reactive MnIII species, and optimized the exposure density of the active sites. Therefore, the sea urchin-like La-doped MnO2 material shows potential for applications in electrochemical sustainability research.

  • Single Zn atoms anchored in mesoporous N-doped carbon rods derived from metal–organic frameworks for enhanced electrocatalytic oxygen reduction reaction

    by Mengxue Ma, Zhuoya Pei, Yuxin Peng, Rong Hua, Yuxing Ma, Weilong Wang, Xiaoxiang Xu, Xuepeng Zhang, Haoquan Zheng

    Nitrogen–carbon (N–C) materials have been recently explored to activate Fenton-reaction-inactive Zn single atoms as active sites for electrocatalytic oxygen reduction reaction (ORR). However, achieving Zn–N–C electrocatalysts with high activity and stability remains challenging. In this study, we introduce a micelle@polydopamine (PDA) layer on the surface of rod-shaped zeolitic imidazolate frameworks (ZIFs). The micelle@PDA layer could not only form a mesoporous carbon layer on the porous carbon rods after pyrolysis in Ar but also captures Zn atoms during their evaporation from the ZIF at high temperatures. As a result, the Zn single-atom catalysts anchored on hollow, multi-hierarchical porous carbon rods (Zn-MCRs) have a high content of N and Zn–Nx active sites on the mesoporous layer. Density functional theory (DFT) calculations reveal that the atomically dispersed Zn–Nx sites are the primary and most active components in N–C materials. Due to the unique one-dimensional hollow, multi-hierarchical porous structure that provides accessible Zn–Nx active sites, the catalyst exhibits an impressive half-wave potential of 873 mV in a 0.1 M KOH solution, matching the ORR activity of Pt/C with exceptional efficiency.


  • Trimetallic mesoporous PdCuRu for efficient formate electrosynthesis from polyethylene terephthalate recycling

    by Yuting Li, Huiqin Yao, Lizhi Sun, Shu Han, Xiaoxiang Xu, Guangyin Fan, Ben Liu


  • Open Access

    Gene therapy: an emerging therapy for hair cells regeneration in the cochlea

    by Jipeng Wang, Jianwei Zheng, Haiyan Wang, Haoying He, Shuang Li, Ya Zhang, You Wang, Xiaoxiang Xu, Shuyi Wang

    Sensorineural hearing loss is typically caused by damage to the cochlear hair cells (HCs) due to external stimuli or because of one’s genetic factors and the inability to convert sound mechanical energy into nerve impulses. Adult mammalian cochlear HCs cannot regenerate spontaneously; therefore, this type of deafness is usually considered irreversible. Studies on the developmental mechanisms of HC differentiation have revealed that nonsensory cells in the cochlea acquire the ability to differentiate into HCs after the overexpression of specific genes, such as Atoh1, which makes HC regeneration possible. Gene therapy, through in vitro selection and editing of target genes, transforms exogenous gene fragments into target cells and alters the expression of genes in target cells to activate the corresponding differentiation developmental program in target cells. This review summarizes the genes that have been associated with the growth and development of cochlear HCs in recent years and provides an overview of gene therapy approaches in the field of HC regeneration. It concludes with a discussion of the limitations of the current therapeutic approaches to facilitate the early implementation of this therapy in a clinical setting.


  • A metal–organic framework based inner ear delivery system for the treatment of noise-induced hearing loss

    by Xiaoxiang Xu, Kun Lin, Yanzhi Wang, Kai Xu, Yu Sun, Xiuping Yang, Minlan Yang, Zuhong He, Ya Zhang, Haoquan Zheng, et al.

    Noise-induced hearing loss (NIHL) is associated with both acute and chronic noise exposure. The application of steroid hormones is the first-line treatment for NIHL. However, a high dose of steroid hormone in the body is necessary to maintain its efficacy and causes side effects, such as headache and osteoporosis. In this work, we prepared a zeolitic imidazolate framework (ZIF)-based system for steroid hormone delivery in the inner ear. Methylprednisolone (MP), a typical steroid hormone, was encapsulated into ZIF-90 nanoparticles (NPs) using one-pot synthesis method. The obtained MP@ZIF-90 NPs are negatively charged and 120 nm in size and showed good biocompatibility and stability at a pH value of 7.4. After intraperitoneal injection, ZIF-90 could efficiently protect drugs during peripheral blood circulation, enter the inner ear via the blood labyrinthine barrier (BLB) and slowly release the drugs. Auditory brainstem response (ABR) tests indicated that MP@ZIF-90 exhibits better protection of mice from noise than those using the free MP and ZIF-8 with encapsulated MP (MP@ZIF-8). More importantly, MP@ZIF-90 showed no defects to the inner ear after being treated for noise and low nephrotoxicity during therapy, which demonstrates the biocompatibility of this material. We believe the ZIF-90 based delivery system is an efficient strategy for inner ear therapy of NIHL.